Observational Study to Investigate the Effects of Training on the Administration of Cardioplexol™

PHASE3CompletedINTERVENTIONAL

Enrollment

171

Participants

Timeline

Start Date

November 20, 2018

Primary Completion Date

October 18, 2021

Study Completion Date

October 18, 2021

Conditions

Coronary Artery Bypass SurgeryValve Surgery

Interventions

DRUG

Cardioplegia Solution

Cardioplexol™ will be adminstered in cardiac surgery as cardioplegic solution

Trial Locations (6)

Krankenhaus Hietzing, Vienna

Universitaetsklnikum St. Pölten, Sankt Pölten

Universitaetsklinikum Salzburg, Salzburg

Universitätsklinik Innsbruck, Innsbruck

Deutsches Herzzentrum Berlin, Berlin

Universitaetsklinikum Frankfurt, Frankfurt

All Listed Sponsors

lead

Swiss Cardio Technologies AG

INDUSTRY

NCT03823521 - Observational Study to Investigate the Effects of Training on the Administration of Cardioplexol™ | Biotech Hunter | Biotech Hunter